• Contact us
Wednesday, November 18, 2026
Register
Login
European Press
ADVERTISEMENT Handpicked deals on Amazon Discover useful products selected for our readers. Explore deals ›
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

UC study finds pancreatic cancer tumor differences in Black patients

17 November 2026
in Health
Reading Time: 4 mins read
A A
UC study finds pancreatic cancer tumor differences in Black patients
ShareShareShareShareShare


NEWYou can now listen to Fox News articles!
A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently, potentially leading to more personalized treatments.Researchers examined 22 pancreatic tumors from patients of different racial backgrounds across the U.S., looking for differences in cancer cells and how the immune system responds to them. The study included seven Black patients and 15 non-African American patients.The findings were published in the journal Cancer Research.FDA APPROVES ONCE-DAILY PILL FOR DEADLY CANCER AFTER PATIENTS’ SURVIVAL RATES NEARLY DOUBLETumors from Black patients had fewer of the most common type of pancreatic cancer cells and more cells with a mix of different characteristics, the researchers found.Some of those cell characteristics have been associated with drug resistance, but the study did not establish whether they affected patients’ treatment outcomes. A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently. (iStock)Additionally, tumors from Black patients contained more B cells, a type of immune cell, and larger clusters of immune cells. Researchers found signs that some B cells may suppress the body’s response to cancer, although the significance of these differences is unclear.PATIENTS REMAIN CANCER-FREE NEARLY 3 YEARS AFTER RECEIVING EXPERIMENTAL IMMUNOTHERAPYDr. Raymond Wadlow, a gastrointestinal medical oncologist at Inova Schar Cancer Institute in Virginia, said that using immunotherapy to help the immune system attack the disease has been particularly challenging in pancreatic cancer.”That’s been very difficult to do in pancreatic cancer because the pancreatic tumor subverts the immune system so that it is fighting for it instead of for the host or the rest of the body,” Wadlow, who was not involved in the study, told Fox News Digital. Tumors from Black patients contained more B cells, a type of immune cell, and larger clusters of immune cells. Researchers found signs that some B cells may suppress the body’s response to cancer. (iStock)The study found no significant differences between groups in the major genetic changes known to drive the disease.Pancreatic cancer is approximately 20% more likely to develop in Black Americans than in non-African Americans, according to the researchers.WHERE YOU LIVE COULD SHAPE YOUR RISK OF CANCER MORTALITY, STUDY SUGGESTSThe findings highlight the importance of including patients from different backgrounds in cancer research, according to lead study author Nina Steele, Ph.D., an assistant professor in UC’s College of Medicine.”This study shows that ignoring diverse ancestry in medical research leaves blind spots in the search for a cure,” she told Fox News Digital. An oncologist (not pictured) encouraged newly diagnosed patients to ask about hereditary genetic testing, which can identify inherited mutations that may also affect relatives. (iStock)Wadlow noted that pancreatic cancers can share major DNA mutations but can differ considerably in how their cells behave and interact with nearby immune cells and surrounding tissue.”Those differences may also vary across patient populations, such as between Black and non-Black patients,” he told Fox News Digital.”While intriguing, these findings are still a long way from changing patient care.” “That is potentially important both for understanding disparities in pancreatic cancer and, ultimately, for developing more individualized treatments.”Pancreatic cancer can vary from one tumor to another, and even within the same tumor, Wadlow explained. “The cancer cell itself is only part of the story,” he said. Pancreatic cancer is approximately 20% more likely to develop in Black Americans than in non-African Americans, according to the researchers. (iStock)The surrounding immune cells and tissue may affect how a tumor behaves and responds to treatment, helping to explain why a single treatment approach may not work for every patient.The findings have several limitations.CLICK HERE FOR MORE HEALTH STORIESResearchers have not established how the intermediate tumor cells affect survival or whether they respond differently to standard chemotherapy, Steele said. The team also needs to study pancreatic tissue from people without cancer to better understand when these differences develop.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERWadlow cautioned that race and genetic ancestry do not fully account for the environmental, socioeconomic and biological factors that could explain the findings.Larger studies involving patients from diverse backgrounds are needed to determine whether these differences affect treatment outcomes or survival, the oncologist said. Immunotherapy to help the immune system attack cancer has been particularly challenging in pancreatic cancer, an oncologist said. (Aaron Chown/PA Images via Getty Images)”While intriguing, these findings are still a long way from changing patient care,” he added.Wadlow encouraged newly diagnosed patients to ask about hereditary genetic testing, which can identify inherited mutations that may also affect relatives.TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ”If we find an inherited mutation, then family members can be tested,” he said.Steele said the findings also underscore the need for clinical trials that represent the patients affected by pancreatic cancer.CLICK HERE TO DOWNLOAD THE FOX NEWS APP”It is also a reminder for the medical system to ensure that clinical trials reflect the entire population at risk, in order to find treatments that can help all patients, not just some patients,” she told Fox News Digital.The research was funded in part by the National Cancer Institute. Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.

Credit: Source link

Previous Post

San Agustin Museum’s conservation lab aims to protect cultural heritage

Next Post

Filipino consumers may remain cautious through 2027 — BMI

Recommended

Inside Staten Island’s wild turkey invasion

Inside Staten Island’s wild turkey invasion

18 November 2026

New Yorkers may be gearing up for their annual Thanksgiving turkey trot next week, lacing up their sneakers and pinning...

Lakers coach JJ Redick knew after this moment Quentin Grimes was in the zone

Lakers coach JJ Redick knew after this moment Quentin Grimes was in the zone

18 November 2026

The eight points scored in each of the first, second and third quarters provided hints that Quentin Grimes was on...

Early Black Friday deal: The Nothing CMF Watch 3 Pro is only $55

Early Black Friday deal: The Nothing CMF Watch 3 Pro is only $55

18 November 2026

SAVE $24: As of Nov. 18, the Nothing CMF Watch 3 Pro is on sale on Amazon for only $55...

‘What even was that?!’ EastEnders fans struggle to unsee cringe Oscar scene in iPlayer episode

‘What even was that?!’ EastEnders fans struggle to unsee cringe Oscar scene in iPlayer episode

18 November 2026

EastEnders spoilers are included in this article about Oscar. The episode has not yet aired on TV, but is available...

Datenschutzinformationen

Disclaimer  Privacy Policy – EU  Imprint 

Join European Press

Contact us

What’s New Here!

  • Inside Staten Island’s wild turkey invasion
  • Lakers coach JJ Redick knew after this moment Quentin Grimes was in the zone
  • Early Black Friday deal: The Nothing CMF Watch 3 Pro is only $55
  • ‘What even was that?!’ EastEnders fans struggle to unsee cringe Oscar scene in iPlayer episode

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

© 2026 European Press. All rights reserved.

European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video

© 2026 European Press. All rights reserved.

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?